Claymont · Pre-Seed–Series A · 5 people tracked
Also known as MBX Capital NYS SSBCI · MBX CAPITAL, LLC
Find your way into MBX Capital
1,179 people in our graph share verified history with the MBX Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
MBX Capital invests at the early stage in what it calls 'deep health' — a broad range of health-focused companies spanning drug discovery, diagnostics, therapeutics, medical AI, care delivery, mental and maternal health, and adjacent green chemistry and life-sciences infrastructure. The firm frequently partners alongside other investors and aims to advance good health for everyone, backing visionary founders tackling significant biological, clinical, and healthcare-access challenges.
Source: firm website, verified Sep 15, 2026.
Team · 5 people
from the firm's website & curated & public directories
Founder mafia
3 people who came through MBX Capital went on to found or lead other companies.
What they invest in
from 28 of 39 portfolio companiesDigital Health ×16Healthtech ×16Biotech ×15AI & Machine Learning ×10Medical Devices ×10Deep Tech ×5Enterprise Software ×2FemTech ×2
HQs:United States×16Mexico×1
Investments · 39 tracked
founders shown can be your intro pathBy year:2026 · 42025 · 32023 · 22022 · 22021 · 32020 · 115 dated
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin Eisenfrats(Co-Founder and CEO)inJohn Herr(Co-Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Martin J Emerson(Director)Tom Thorpe(Director)
Board seatGurdane Bhutani· per SEC Form D
Co-investorsBiotechnology Value FundAllied Venture PartnersAmboy Street VenturesAurum Venture PartnersBeni Venture CapitalCleo Capital+15 more
Junction Health partners with Federally Qualified Health Centers (FQHCs) to set up and manage IV infusion therapy sites, expanding access to infusion services for chronically ill, uninsured, Medicaid, and underserved patients across the US.
Digital HealthHealthtechImpact & Social GoodMedical DevicesDenver, US
Ben Wiederholt(Co-founder & CEO)inVinny Polito(Co-founder & COO)inMatt Vestal(Co-founder & Chief Commercial Officer)in
BoardJason Hill(Director)
Board seatGurdane Bhutani· per SEC Form D
Arine provides an AI-driven medication management platform for health plans to improve medication adherence and outcomes.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Yoona Kim(Executive Officer, Director)inBen Thomander(Executive Officer)Eric Carlson(Chief Financial Officer)Penjit Moorhead(Chief Technology Officer)Penjit Moorehead(Executive Officer, Director)
BoardSusan Choe(Director)in
Co-investorsKaiser Permanente VenturesKatalyst VenturesKatalyst.VenturesLifelike CapitalMaC Venture CapitalSerasa Experian
Atlas Health uses AI-driven patient assistance to help health systems connect patients to financial resources and reduce barriers to care.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtech
Ethan Davidoff(Founder)in
Co-investorsFelicis VenturesFinancial Venture StudioOptum VenturesRestive VenturesGlobal Founders CapitalGreatPoint Ventures+1 more
.png)
Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.
AI & Machine LearningBiotechMedical DevicesNatick, US
Edward Doherty(Executive Officer)Jessica McDonough(Director)Joaquim Trias(Executive Officer, Director)
BoardZeshan Muhammedi(Director)in
Co-investorsUlu VenturesAxial VCEmbark Ventures
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Marco Lobba(Founder)inMatthew Francis(Founder)in
Co-investorsCALIFORNIA INNOVATIONCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Iaso VenturesY CombinatorAxial VC+2 more
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Co-founder)inDr. David Suhy(Co-founder & Chief Scientific Officer)
BoardJustin Kao(Director)inJorge Conde(Director)in
Co-investorsAndreessen HorowitzBreyer CapitalHan River PartnersMenlo VenturesDFJKhosla Ventures
Enoda develops synthetic cytokine receptors, called MIMICs, that link therapeutic "Signal 3" cytokine functions to controllable inputs to engineer cell therapies without systemic toxicity.
BiotechDeep TechLondon
Andrew John Scobie(Executive Officer, Director)Michael Chavez(Co-founder & CEO)inPaul B. Finn(Founder)inJennifer Urquhart(Executive Officer, Director)inJacqueline Elizabeth Porch(Executive Officer, Director)Lindsay James Whitelaw(Executive Officer, Director)
Co-investorsFifty Years
EvaCenter develops a cloud-based RIS/PACS system for radiology departments in Latin America, offering features like rapid DICOM image loading, multiplanar reconstruction, and automated patient communication.
Cloud ComputingDigital HealthHealthtechMedical DevicesSaaSMexico City, MX
Fathom structures and organizes healthcare data to address inefficiencies in the healthcare system.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechOakland, US
Andrew(CEO)Chris(CTO)Enoch(COO)
Co-investorsLightspeed Venture PartnersFounders FundGV (Google Ventures)Alkeon InnovationGreat Oaks Venture CapitalLifeforce Capital+2 more
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in
Co-investorsBeni Venture CapitalEvolution VC PartnersIter InvestmentsLongeVCManta Ray VenturesPsyMed Ventures+1 more
ixlayer provides a platform that connects biopharma companies with patients, labs, providers, and payment systems to deploy personalized patient experience programs powered by AI.
AI & Machine LearningDigital HealthHealthtechSaaS
Pouria Sanae(Co-founder and Chief Executive Officer)Poorya Sabounchi(Co-founder and Chief Operating Officer)
Co-investorsBIOSPRING PARTNERSInitiate Venture PartnersNimble PartnersXYZ Venture Capital
Psychedelic therapies for addiction.
BiotechSan Francisco, US
Jeeshan Chowdhury(Executive Officer, Director, Promoter)in
BoardSam Altman(Director)Krishna Kantheti(Director)
Co-investorsAPOLLO PROJECTSLIONHEART VENTURES
Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample.
BiotechDigital HealthFemTech
Co-investorsAmboy Street VenturesDria VenturesBlue CollectiveCompany VenturesInnospark Ventures
Keebler Health, founded in 2023, is a healthcare company focused on improving efficiency and efficacy in the healthcare industry.
AI & Machine LearningDigital HealthHealthtech
Isaac Park(CEO)inAndrew Stickney(COO)inKevin Hill(CTO)inTerrell Bacchus(CMO)in
Co-investorsFlare Capital PartnersHustle FundHypothesisNew Stack VenturesPrimordial VenturesTau Ventures+8 more
Macro Trials optimizes clinical trial enrollment by connecting research sponsors with eye care practices and patients, enabling efficient trials with reliable data collection and patient access to new treatments through trusted local providers.
BiotechDigital HealthHealthtechMedical Devices
Jon Cabin, M.D.(Co-Founder and Chief Medical Officer)Jon Cabin(Co-Founder and Chief Medical Officer)Brooke LeVasseur(President & Chief Executive Officer)
Co-investorsHealthy VenturesInitiate Venture PartnersInflect Health
.png)
Mae provides community-based doula support and maternal health education for pregnant people, integrating with insurance and Medicaid to match mothers with doulas and care coordinators.
Digital HealthFemTechHealthtechNew York City, US
Maya Hardigan(Founder)in
Co-investorsAstiaBright VenturesForeground CapitalJoyance PartnersJumpstart NovaSocial Starts+2 more
OFFOR Health provides mobile healthcare services to underserved populations in the United States, operating SmileMD for in-office anesthesia and sedation during pediatric dental procedures and IH Care+ for integrated health access.
Digital HealthHealthtechMedical DevicesWorthington, US
Gary Schafer(Chief Executive Officer)inAlex Ramos(Chief Operations Officer)Brian Schloss(Chief Medical Officer)in
Co-investorsAtlantic Vantage PointAXA Venture PartnersHavencrest Capital ManagementLOUD CapitalSPRINGROCK VENTURES
Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
AI & Machine LearningBiotechHealthtechMedical DevicesRoboticsSacramento, US
Karthik Raman(Founder)inChristopher Shelner(Founder)in
Co-investors2048 VenturesGlobal BrainGood AI CapitalJovonoSpero VenturesY Combinator+1 more
Rula operates a digital mental health platform connecting patients with licensed therapists for remote behavioral care.
Digital HealthHealthtechMental Health
Josh Bruno(Founder & CEO)in
Co-investorsBlue Venture FundsHarmony PartnersIcon VenturesKoch Disruptive TechnologiesMeridian Street CapitalPROOF+4 more
Smiles.ai (also branded Dezy) provides dental care including clear/invisible aligners, implants, and crowns through a network of clinics, using specialist orthodontists and at-home scanning.
ConsumerDigital HealthHealthtech
Jatin Kakrani(Founder)inHitesh Kakrani(Founder)in
Co-investorsAlpha Wave GlobalDIA
Tidal Cyber develops tools and services that help enterprises adopt MITRE ATT&CK framework for threat-informed defense.
CybersecurityEnterprise Software
Co-investorsAccess Venture PartnersBright Pixel CapitalDreamit VenturesGlasswing VenturesStoneMill VenturesTFX Capital+8 more
Tidal Vision produces chitosan-based solutions for applications including water treatment, agriculture, and material science.
AgTechCleantechNew MaterialsBellingham, US
Craig Kasberg(Founder & CEO)in
BoardRoeland van der Molen(Director)Arkadi Nachimowski(Director)Filipp Chebotarev(Director)Zachary Wilkinson(Director)Amrit Jalan(Director)in
Co-investorsConvent Capital Management AFFGiant Ventures Global LlpPangaea Ventures Us Inc.Snatched Ventures
Vaxxinity develops vaccines designed to be long-lasting, well tolerated, and cost-effective, with protection against emerging variants and no requirement for a frozen cold chain, mRNA, or spike protein.
BiotechHealthtech
Co-investorsPrime Movers Lab
VitalBio develops the VitalOne, a diagnostic device that delivers comprehensive lab-grade blood test results in minutes from a small blood sample, using robotics, biochemistry, computer vision, and microfluidics.
BiotechDigital HealthMedical Devices
Vasu Nadella(Founder)in
Co-investorsNext VenturesInovia CapitalLachy GroomMarc BenioffNorthpond VenturesSam Altman+6 more
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.
AI & Machine LearningBiotechDeep TechBrisbane, US
Andrei Georgescu(Executive Officer, Director)inDongeun Huh(Executive Officer, Director)Andrei Georgescu, Ph.D.(Founder)in
BoardQuinten Stevens(Director)Alex Andrianopolous(Director)Alex Morgan(Director)in
Co-investorsBison VenturesKairos Venture Investments, LlcKhosla VenturesFortius Ventures
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in
Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMitsui Global InvestmentRecode VenturesAmplify Partners CV+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Neurofold TherapeuticsDezyEva TechForumFreedom BioJoinforumJuniperMae HealthSecureAireVaxxinityVital Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Smiles · castanetkamloops.net · Aug 25, 2026
Contraline · fiercebiotech.com · Aug 12, 2026
Waypoint Bio · finsmes.com · Jun 2, 2026
Tidal · esgtoday.com · May 29, 2026
Atlas Health · macfarlanes.com · May 5, 2026
Keebler Health · flarecapital.com · Apr 21, 2026
OFFOR Health · prnewswire.com · Apr 9, 2026
Frequently asked questions
- How many investments has MBX Capital made?
- MBX Capital has 39 tracked investments, including 7 dated in the last 24 months.
- What stage does MBX Capital invest at?
- MBX Capital invests at the Pre-Seed, Seed, Series A stages.
- What is MBX Capital's typical check size?
- MBX Capital typically writes checks of $250K – $2.5M.
- What sectors does MBX Capital focus on?
- MBX Capital focuses on AI & Machine Learning, Biotech, Digital Health, FemTech, Healthtech, Medical Devices, Mental Health.
- Where is MBX Capital located?
- MBX Capital is headquartered in Claymont, US.
- Does MBX Capital lead rounds?
- MBX Capital typically participates in rounds rather than leading them.
- Who does MBX Capital co-invest with?
- MBX Capital most often shares deals with Fifty Years, Amplify Partners, Hummingbird Ventures, among 10 tracked co-investors.
Co-investors · 9
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Biospring Partners invests in technology-enabled, EBITDA-positive pharma services businesses focused on advancing manufacturing and clinical trial services for the life sciences industry.
Uber is a technology company operating multisided platforms that connect consumers with ride services, transit, delivery of food and groceries, and freight shipping across more than 70 countries and 15,000+ cities.
Plug and Play is an innovation platform that connects corporations, governments, startups, investors, and universities to drive innovation.
Cota Capital is an investment firm focused on founders building net-new enterprise technology, combining capital with operational expertise, industry insight, competitive intelligence, and a broad network.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Pear VC is a venture capital firm that backs founders from the earliest stages through its PearX accelerator and seed investing programs.
23andMe Research Institute is a genetic research organization that unites a community of 11 million members to advance health discoveries and deepen understanding of human DNA through collaborative research. The institute operates a cycle where members contribute genetic data that fuels research, which produces insights and breakthroughs that flow back to members and society.
Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.
Firms observed investing alongside MBX Capital, from public investor directories. Shared companies are the overlap with MBX Capital's recorded portfolio.
Similar investors
MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Wavemaker 360 is a healthcare-focused venture capital firm that backs entrepreneurs building disruptive companies transforming the healthcare industry. Its limited partners are largely individuals with significant healthcare industry experience.
WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.